Mainolfi Nello 4
4 · Kymera Therapeutics, Inc. · Filed Dec 17, 2025
Insider Transaction Report
Form 4
Mainolfi Nello
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-17$38.53/sh+2,595$99,985→ 663,077 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-17−2,595→ 272,505 totalExercise: $38.53Exp: 2032-03-01→ Common Stock (2,595 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option are fully vested and exercisable.